2010•Zhongguo yaofangRequires access

Study on Pharmacokinetics and Bioequivalence of Simvastatin Sustained Release Tablets in Beagle Dogs

Yupeng Wang

Open publisher page 0 citations

Abstract

OBJECTIVE:To study pharmacokinetics and bioequivalence of Simvastatin sustained release tablets in healthy beagle dogs.METHODS:6 beagle dogs were randomized into two groups.They received oral single dose of Simvastatin sustained release tablets 20 mg(test tablet) or Simvastatin tablets for sale(reference tablet).Plasma samples were collected at different time points.Plasma concentration of simvastatin acid was determined by LC-MS/MS and pharmacokinetic parameters were calculated.RESULTS:The pharmacokinetic parameters of reference tablet vs.test tablet were as follows:Cmax:(23.461±6.043) ng·mL-1 vs.(13.942±3.236) ng·mL-1;tmax:(2.158±0.396) h vs.(4.116±1.145 3) h;t1/2:(4.564±0.645) h vs.(8.143±0.679) h;AUC0~24 h:(118.647±31.989) ng·h·mL-1 vs.(129.977±29.853) ng·h·mL-1.CONCLUSIONS:The absorption rate of test tablet is different from that of reference tablet.The two kinds of tablets are not bioequivalent.

About this research paper

What this paper is about

OBJECTIVE:To study pharmacokinetics and bioequivalence of Simvastatin sustained release tablets in healthy beagle dogs.METHODS:6 beagle dogs were randomized into two groups.They received oral single dose of Simvastatin sustained release tablets 20 mg(test tablet) or Simvastatin tablets for sale(reference tablet).Plasma samples were collected at different time points.Plasma concentration of simvastatin acid was determined by LC-MS/MS and pharmacokinetic parameters were calculated.RESULTS:The pharmacokinetic parameters of reference tablet vs.test tablet were as follows:Cmax:(23.461±6.043) ng·mL-1 vs.(13.942±3.236) ng·mL-1;tmax:(2.158±0.396) h vs.(4.116±1.145 3) h;t1/2:(4.564±0.645) h vs.(8.143±0.679) h;AUC0~24 h:(118.647±31.989) ng·h·mL-1 vs.(129.977±29.853) ng·h·mL-1.CONCLUSIONS:The absorption rate of test tablet is different from that of reference tablet.The two kinds of tablets are not bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To study pharmacokinetics and bioequivalence of Simvastatin sustained release tablets in healthy beagle dogs.METHODS:6 beagle dogs were randomized into two groups.They received oral single dose of Simvastatin sustained release tablets 20 mg(test tablet) or Simvastatin tablets for sale(reference tablet).Plasma samples were collected at different time points.Plasma concentration of simvastatin acid was determined by LC-MS/MS and pharmacokinetic parameters were calculated.RESULTS:The pharmacokinetic parameters of reference tablet vs.test tablet were as follows:Cmax:(23.461±6.043) ng·mL-1 vs.(13.942±3.236) ng·mL-1;tmax:(2.158±0.396) h vs.(4.116±1.145 3) h;t1/2:(4.564±0.645) h vs.(8.143±0.679) h;AUC0~24 h:(118.647±31.989) ng·h·mL-1 vs.(129.977±29.853) ng·h·mL-1.CONCLUSIONS:The absorption rate of test tablet is different from that of reference tablet.The two kinds of tablets are not bioequivalent.

Key concepts: Bioequivalence, Beagle, Simvastatin, Pharmacokinetics, Cmax, Pharmacology, Medicine, Plasma concentration

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on Pharmacokinetics and Bioequivalence of Simvastatin Sustained Release Tablets in Beagle Dogs — Research Paper | ScholarLens